Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Cidara Therapeutics (CDTX) Accumulated Depreciation & Amortization: 2017-2024

Historic Accumulated Depreciation & Amortization for Cidara Therapeutics (CDTX) over the last 2 years, with Dec 2024 value amounting to $3.3 million.

  • Cidara Therapeutics' Accumulated Depreciation & Amortization rose 10033.33% to $3.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.4 million, marking a year-over-year increase of 2957.14%. This contributed to the annual value of $200,000 for FY2024, which is 78.57% up from last year.
  • According to the latest figures from Q4 2024, Cidara Therapeutics' Accumulated Depreciation & Amortization is $3.3 million, which was up 10,033.33% from $33,000 recorded in Q4 2023.
  • Over the past 5 years, Cidara Therapeutics' Accumulated Depreciation & Amortization peaked at $3.3 million during Q4 2024, and registered a low of $22,000 during Q3 2023.
  • Over the past 3 years, Cidara Therapeutics' median Accumulated Depreciation & Amortization value was $33,000 (recorded in 2023), while the average stood at $399,889.
  • In the last 5 years, Cidara Therapeutics' Accumulated Depreciation & Amortization tumbled by 99.10% in 2022 and then skyrocketed by 10,033.33% in 2024.
  • Over the past 5 years, Cidara Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $3.1 million in 2020, then rose by 5.64% to $3.2 million in 2021, then plummeted by 99.10% to $29,000 in 2022, then grew by 13.79% to $33,000 in 2023, then spiked by 10,033.33% to $3.3 million in 2024.
  • Its Accumulated Depreciation & Amortization stands at $3.3 million for Q4 2024, versus $33,000 for Q4 2023 and $22,000 for Q3 2023.